Molecular mechanisms involved in NAFLD progression

被引:246
作者
Malaguarnera, Mariano [2 ]
Di Rosa, Michelino [1 ]
Nicoletti, Ferdinando [1 ]
Malaguarnera, Lucia [1 ]
机构
[1] Univ Catania, Dept Biomed Sci, I-95124 Catania, Italy
[2] Univ Catania, Dept Internal Med, I-95124 Catania, Italy
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2009年 / 87卷 / 07期
关键词
Non-alcoholic steatohepatitis; Hepatocellular damage; Insulin resistance; Oxidative stress; Gene's abnormality; NONALCOHOLIC FATTY LIVER; TUMOR-NECROSIS-FACTOR; ACTIVATED PROTEIN-KINASE; TRIGLYCERIDE TRANSFER PROTEIN; TRANSCRIPTION FACTOR FOXO1; HEPATIC STELLATE CELLS; NF-KAPPA-B; INSULIN-RECEPTOR SUBSTRATE-1; STRESS-RELATED PARAMETERS; ACETYL-COA CARBOXYLASE-2;
D O I
10.1007/s00109-009-0464-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is an emerging metabolic-related disorder characterized by fatty infiltration of the liver in the absence of alcohol consumption. NAFLD ranges from simple steatosis to non-alcoholic steatohepatitis (NASH), which might progress to end-stage liver disease. This progression is related to the insulin resistance, which is strongly linked to the metabolic syndrome consisting of central obesity, diabetes mellitus, and hypertension. Earlier, the increased concentration of intracellular fatty acids within hepatocytes leads to steatosis. Subsequently, multifactorial complex interactions between nutritional factors, lifestyle, and genetic determinants promote necrosis, inflammation, fibrosis, and hepatocellular damage. Up to now, many studies have revealed the mechanism associated with insulin resistance, whereas the mechanisms related to the molecular components have been incompletely characterized. This review aims to assess the potential molecular mediators initiating and supporting the progression of NASH to establish precocious diagnosis and to plan more specific treatment for this disease.
引用
收藏
页码:679 / 695
页数:17
相关论文
共 171 条
[1]   Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets [J].
Abu-Elheiga, L ;
Oh, WK ;
Kordari, P ;
Wakil, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (18) :10207-10212
[2]   The subcellular localization of acetyl-CoA carboxylase 2 [J].
Abu-Elheiga, L ;
Brinkley, WR ;
Zhong, L ;
Chirala, SS ;
Woldegiorgis, G ;
Wakil, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) :1444-1449
[3]   Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2 [J].
Abu-Elheiga, L ;
Matzuk, MM ;
Abo-Hashema, KAH ;
Wakil, SJ .
SCIENCE, 2001, 291 (5513) :2613-2616
[4]   Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction [J].
Adams, LA ;
Feldstein, A ;
Lindor, KD ;
Angulo, P .
HEPATOLOGY, 2004, 39 (04) :909-914
[5]   Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH) [J].
Agarwal, N ;
Sharma, BC .
HEPATOLOGY RESEARCH, 2005, 33 (02) :92-96
[6]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[7]   IKK-β links inflammation to obesity-induced insulin resistance [J].
Arkan, MC ;
Hevener, AL ;
Greten, FR ;
Maeda, S ;
Li, ZW ;
Long, JM ;
Wynshaw-Boris, A ;
Poli, G ;
Olefsky, J ;
Karin, M .
NATURE MEDICINE, 2005, 11 (02) :191-198
[8]   Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis [J].
Balas, Bogdan ;
Belfort, Renata ;
Harrison, Stephen A. ;
Darland, Celia ;
Finch, Joan ;
Schenker, Steven ;
Gastaldelli, Amalia ;
Cusi, Kenneth .
JOURNAL OF HEPATOLOGY, 2007, 47 (04) :565-570
[9]   Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis [J].
Baskol, Gulden ;
Baskol, Mevlut ;
Kocer, Derya .
CLINICAL BIOCHEMISTRY, 2007, 40 (11) :776-780
[10]  
Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4